title: Hypothalamic suppression during adolescence varies by bone envelope.
abstract: OBJECTIVE
  The purposes of this study were to suppress estradiol levels in adolescent (postpubertal rats) using gonadotropin-releasing hormone antagonist (GnRH-a) injections and to determine the changes in bone structure and mechanical strength.
  
  
  METHODS
  In an Institutional Animal Care and Use Committee-approved study, female rats at 23 d of age were assigned to a baseline group (BL65; n = 10) sacrificed on day 65, a control group (Control; n = 15) sacrificed on day 90, or an experimental group (AMEN; n = 9) sacrificed on day 90 that received daily injections of GnRH-a for a 25-d period from 65 to 90 d of age (2.5 mg·kg(-1) per dose).
  
  
  RESULTS
  Body weights were similar on day 65; however, the AMEN group was significantly heavier than the Control group (17%, P = 0.001) on day 90. In the AMEN rats relative to the Control group, plasma estradiol levels were reduced by 36% (P = 0.0001) and plasma insulin-like growth factor 1 levels were 24% higher (P = 0.003). In the femur, there was no change in periosteal bone apposition or total cross-sectional area. The marrow area increased by 13.7% (P = 0.05) resulting in a 7.8% decrease in relative cortical area (P = 0.012), and endocortical bone formation rate increased by 39.4% (P = 0.04). Trabecular volume and number decreased by 51.5% (P = 0.0003) and 49.5% (P = 0.0003), respectively. The absolute peak moments of the tibiae and femurs were unchanged in the AMEN group relative to the Control group, but these were reduced by 8.8% (P = 0.03) and 7.5% (P = 0.09), respectively, when normalized by body weight.
  
  
  CONCLUSIONS
  Suppression of estradiol by 25 d of GnRH-a administration to 65-d-old (postpubertal) rats reduced trabecular volume and number by about 50%, increased endocortical bone turnover, and reduced relative cortical thickness without changing tibial and femoral total area. These changes in bone structure were associated with no change in absolute mechanical strength possibly because of increases in body weight or in insulin-like growth factor 1 concentrations.
authors.affiliation: Department of Anthropology, College of Liberal Arts, Temple University, Philadelphia, PA, USA.
authors.forename: McKayla Elle
authors.initials: ME
authors.lastname: Saine
authors.forename: Mary F
authors.initials: MF
authors.lastname: Barbe
authors.forename: Mobin Rastgar
authors.initials: MR
authors.lastname: Agah
authors.forename: Vanessa R
authors.initials: VR
authors.lastname: Yingling
mesh_terms: D000818:Animals; D001696:Biomechanical Phenomena / Q000187:drug effects; D001774:Blood Chemical Analysis; D001835:Body Weight / Q000187:drug effects; D001842:Bone and Bones / Q000187:drug effects / Q000378:metabolism*; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D007987:Gonadotropin-Releasing Hormone; D004958:Estradiol
references.citation: J Bone Miner Res. 1987 Apr;2(2):115-22
references.pmid: 3455160
references.citation: J Clin Endocrinol Metab. 2007 Feb;92(2):641-7
references.pmid: 17105837
references.citation: Rheumatology (Oxford). 2008 Jul;47 Suppl 4:iv2-8
references.pmid: 18556646
references.citation: J Clin Endocrinol Metab. 1990 Nov;71(5):1083-8
references.pmid: 2229273
references.citation: J Clin Endocrinol Metab. 2001 Oct;86(10):4674-8
references.pmid: 11600524
references.citation: Ann Intern Med. 1995 Jul 1;123(1):27-31
references.pmid: 7762910
references.citation: J Bone Miner Res. 2008 May;23(5):694-704
references.pmid: 18433303
references.citation: J Bone Miner Res. 1987 Dec;2(6):595-610
references.pmid: 3455637
references.citation: Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1172-80
references.pmid: 18812464
references.citation: J Clin Endocrinol Metab. 2002 Jul;87(7):3162-8
references.pmid: 12107218
references.citation: J Bone Miner Res. 1998 Aug;13(8):1243-50
references.pmid: 9718192
references.citation: Calcif Tissue Int. 1999 Feb;64(2):117-25
references.pmid: 9914318
references.citation: Bone. 1993 Jul-Aug;14(4):595-608
references.pmid: 8274302
references.citation: J Bone Miner Res. 2005 Dec;20(12):2150-8
references.pmid: 16294268
references.citation: Fertil Steril. 2007 Oct;88(4):971-5
references.pmid: 17418159
references.citation: J Clin Invest. 1998 May 1;101(9):1942-50
references.pmid: 9576759
references.citation: Pediatr Res. 2004 Jan;55(1):126-33
references.pmid: 14605254
references.citation: Sports Med. 2005;35(9):747-55
references.pmid: 16138785
references.citation: Curr Sports Med Rep. 2005 Feb;4(1):38-44
references.pmid: 15659278
references.citation: J Clin Endocrinol Metab. 2006 Feb;91(2):378-82
references.pmid: 16303833
references.citation: Med J Aust. 1990 Oct 1;153(7):373-6
references.pmid: 2098012
references.citation: J Bone Miner Res. 2000 Nov;15(11):2245-50
references.pmid: 11092406
references.citation: Bone. 2007 Sep;41(3):371-7
references.pmid: 17572167
references.citation: AJR Am J Roentgenol. 2005 Apr;184(4):1215-9
references.pmid: 15788597
references.citation: Exerc Sport Sci Rev. 2004 Apr;32(2):64-8
references.pmid: 15064650
references.citation: J Appl Physiol (1985). 2000 Jan;88(1):265-71
references.pmid: 10642389
references.citation: Arch Pediatr Adolesc Med. 2000 Jun;154(6):542-3
references.pmid: 10850498
references.citation: J Bone Miner Res. 2001 Nov;16(11):1937-47
references.pmid: 11697789
references.citation: J Bone Miner Res. 1999 Dec;14(12):2159-66
references.pmid: 10620076
references.citation: N Engl J Med. 1984 Aug 2;311(5):277-81
references.pmid: 6738640
references.citation: Bone. 2008 Jun;42(6):1137-43
references.pmid: 18406225
references.citation: J Bone Miner Res. 2003 Feb;18(2):352-9
references.pmid: 12568413
references.citation: Bone. 1997 Jun;20(6):539-45
references.pmid: 9177868